• Factors ID’d for Strong Antibody Response in COVID-19

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health October 26, 2020
  • COVID-19 Pandemic Challenges Osteoporosis Management

    Healthday News COVID-19, Family Practice, Geriatrics, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health October 26, 2020
  • AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health, Pharmacy October 26, 2020
  • Survival From COVID-19 High in Patients With Psoriasis

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, Pharmacy October 23, 2020
  • FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health, Pharmacy October 23, 2020

Sponsored by Janssen Pharmaceuticals, Inc. Intended for Healthcare Professionals

cushing-and-endogenous-hypercortisolism.com
Navigation
  • COVID-19
  • Latest News
  • Travel Vaccine News
  • Influenza Vaccine News
  • Search
  • COVID-19
  • Latest News
  • Travel Vaccine News
  • Influenza Vaccine News
  • Search
Home 2022 February 1

Post Archive by Day

View Post

Remdesivir Offers Some Benefit for Hospitalized COVID-19 Patients

In COVID-19, Latest News
by Healthday
February 1, 2022

No difference seen for in-hospital mortality, but need for initiation of mechanical ventilation reduced with addition of remdesivir to standard care

View Post

SARS-CoV-2 Antibody Tests Should Not Be Used for Diagnosis

In COVID-19, Latest News
by Healthday
February 1, 2022

Related review shows that recent infection protected against symptomatic reinfection with the wild-type or alpha variant of SARS-CoV-2

View Post

First Shots Given in Trial of Moderna mRNA-Based HIV Vaccine

In COVID-19, Latest News
by Healthday
February 1, 2022

Vaccine uses mRNA technology to deliver HIV-specific antigens that could trigger an immune response against the virus

View Post

Pfizer Will Ask FDA to Approve Its COVID-19 Vaccine for Children Under 5 Years

In COVID-19, Latest News
by Healthday
February 1, 2022

If approved, the two-shot regimen would become the first approved for use in children this young

TRENDING

  • Malaria Monoclonal Antibody Provides Some Protection
  • New World Screwworm Confirmed in Nuevo Leon
  • UK Vaccination Campaign Protects Newborns this Winter
  • Should Canada and Mexico Visitors Verify Measles Immunity
  • New Vaccine Panel Recommends Doctor Consults Before COVID Shots

By Publish Date

February 2022
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28  
« Jan   Mar »

LATEST ARTICLES

  • Malaria Monoclonal Antibody Provides Some Protection September 25, 2025
  • New World Screwworm Confirmed in Nuevo Leon September 22, 2025
  • UK Vaccination Campaign Protects Newborns this Winter September 22, 2025

Sponsored by Janssen Pharmaceuticals, Inc. Intended for U.S. Healthcare Professionals.

Powered by eHealthcare Solutions. | Privacy Policy

  • COVID-19
  • Travel Vaccine News
  • Family Practice
  • OBGYN & Women’s Health
  • Clinical Guidelines
eHealthcare Solutions (EHS) manages advertising on this website. We use cookies to ensure that we give you the best experience on our website. By continuing, you agree to the use of cookies as per the EHS Privacy Policy